TenSixty Bio

TenSixty Bio is an oncology-focused biotechnology company based in Cambridge, Massachusetts, working to revolutionize the treatment of cancer. The company combines biology, machine learning, and high-throughput technologies to build an atlas of antibody targets on the surface of cancer cells, discover novel cancer targets, and develop improved therapeutics from bench to bedside. TenSixty Bio is a privately held research-stage company backed by General Catalyst and Wing Venture Capital, and it does not currently publish a public API, developer portal, or SDKs. This profile was surfaced through the API Evangelist venture-capital portfolio pipeline and enriched with verified public company identity.

TenSixty Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Oncology, Cancer, and Machine-Learning.

🌐 Visit website 📡 Source on GitHub
3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyOncologyCancerMachine-LearningAntibody DiscoveryTherapeuticsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/tensixty-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Tensixty Bio Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: tensixty-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/tensixty-bio.png
name: TenSixty Bio
description: TenSixty Bio is an oncology-focused biotechnology company based in Cambridge, Massachusetts, working to revolutionize
  the treatment of cancer. The company combines biology, machine learning, and high-throughput technologies to build an atlas
  of antibody targets on the surface of cancer cells, discover novel cancer targets, and develop improved therapeutics from
  bench to bedside. TenSixty Bio is a privately held research-stage company backed by General Catalyst and Wing Venture Capital,
  and it does not currently publish a public API, developer portal, or SDKs. This profile was surfaced through the API Evangelist
  venture-capital portfolio pipeline and enriched with verified public company identity.
url: https://raw.githubusercontent.com/api-evangelist/tensixty-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
- wing-venture-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Oncology
- Cancer
- Machine-Learning
- Antibody Discovery
- Therapeutics
- Life Sciences
tags_raw:
- Company
- Biotechnology
- Oncology
- Cancer
- Machine Learning
- Antibody Discovery
- Therapeutics
- Life Sciences
apis: []
common:
- type: DomainSecurity
  url: security/tensixty-bio-domain-security.yml
- type: Website
  url: https://www.tensixty.bio
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io